142 related articles for article (PubMed ID: 9630163)
1. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines.
Diab A; Michael L; Wahren B; Deng GM; Björk J; Hedlund G; Zhu J
J Neuroimmunol; 1998 May; 85(2):146-54. PubMed ID: 9630163
[TBL] [Abstract][Full Text] [Related]
2. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats.
Zhu J; Diab A; Mustafa M; Levi M; Wahren B; Björk J; Hedlund G
J Neurol Sci; 1998 Oct; 160(2):113-20. PubMed ID: 9849793
[TBL] [Abstract][Full Text] [Related]
3. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
5. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.
Zhang GX; Yu LY; Shi FD; Xiao BG; Björk J; Hedlund G; Link H
J Neuroimmunol; 1997 Mar; 73(1-2):175-82. PubMed ID: 9058774
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
7. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions.
Bai XF; Shi FD; Zhu J; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 1997 Jun; 76(1-2):177-84. PubMed ID: 9184648
[TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue.
Zou LP; Abbas N; Volkmann I; Nennesmo I; Levi M; Wahren B; Winblad B; Hedlund G; Zhu J
Neuropharmacology; 2002 Apr; 42(5):731-9. PubMed ID: 11985832
[TBL] [Abstract][Full Text] [Related]
9. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
Karussis D; Abramsky O; Rosenthal Y; Mizrachi-Koll R; Ovadia H
Immunol Lett; 1999 Apr; 67(3):203-8. PubMed ID: 10369127
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
Lehmann D; Karussis DM; Fluresco D; Mizrachi-Koll R; Ovadia H; Shezen E; Kalland T; Abramsky O
J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
[TBL] [Abstract][Full Text] [Related]
11. Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells.
Xiao BG; Bail XF; Zhang GX; Hedlund G; Link H
Neurosci Lett; 1998 Jun; 249(1):17-20. PubMed ID: 9672378
[TBL] [Abstract][Full Text] [Related]
12. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.
Tian WZ; Navikas V; Matusevicius D; Söderström M; Fredrikson S; Hedlund G; Link H
Acta Neurol Scand; 1998 Aug; 98(2):94-101. PubMed ID: 9724006
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.
Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J
Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763
[TBL] [Abstract][Full Text] [Related]
14. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Yang JS; Xu LY; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 2004 Nov; 156(1-2):3-9. PubMed ID: 15465591
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
16. The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Morecki S; Nabet C; Falk P; Fridkis-Hareli M; Pecht I; Mond JJ; Slavin S
Autoimmunity; 1997; 25(4):223-32. PubMed ID: 9344330
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autoimmune disease by the immunomodulator linomide correlates with the ability to activate macrophages.
Dahlén E; Andersson M; Dawe K; Tellander AC; Brunmark C; Björk A; Hedlund G
Autoimmunity; 2000 Oct; 32(3):199-211. PubMed ID: 11092700
[TBL] [Abstract][Full Text] [Related]
18. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein.
Harness J; Pender MP; McCombe PA
J Neurol Sci; 2001 Jun; 187(1-2):7-16. PubMed ID: 11440739
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
